AIN2/3
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) (NCT03100045) | Johns Hopkins University | 2017-04-20 |
Track AIN2/3 automatically
Every clearance here is in the API, with alerts when new ones post.